Editas Medicine, Inc.
Hedge Funds Holdings
Last updated:
Editas Medicine, Inc.‘s stocks are currently a part of 237 hedge funds’ portfolios, which represents 68.79% of the total amount of its stocks outstanding. This makes up a total of 47.11M shares of Editas Medicine, Inc.. Compared to the previous quarter, the number grew by 5.09% or 2.28M shares more. As for the holding position changes, 30.38% (72) of current hedge fund investors increased the number of shares held, 27.85% (66) of current holders sold a part of the shares held, and 15.61% (37) closed the holdings completely. 37 hedge funds are new holders of Editas Medicine, Inc. stock in Q2 2022, it is 15.61% of total holders.
Hedge funds holding Editas Medicine (Q3 2017 – Q2 2022)
| Q3 2017 | 114 |
|---|---|
| Q4 2017 | 147 |
| Q1 2018 | 193 |
| Q2 2018 | 211 |
| Q3 2018 | 195 |
| Q4 2018 | 187 |
| Q1 2019 | 193 |
| Q2 2019 | 185 |
| Q3 2019 | 178 |
| Q4 2019 | 218 |
| Q1 2020 | 188 |
| Q2 2020 | 229 |
| Q3 2020 | 231 |
| Q4 2020 | 302 |
| Q1 2021 | 298 |
| Q2 2021 | 304 |
| Q3 2021 | 303 |
| Q4 2021 | 297 |
| Q1 2022 | 239 |
| Q2 2022 | 237 |
Hedge funds changes in Editas Medicine positions (Q3 2017 – Q2 2022)
| Q3 2017 | 23 | 36 | 26 | 16 | 13 |
|---|---|---|---|---|---|
| Q4 2017 | 52 | 45 | 24 | 17 | 9 |
| Q1 2018 | 62 | 68 | 30 | 15 | 18 |
| Q2 2018 | 45 | 72 | 54 | 24 | 16 |
| Q3 2018 | 26 | 67 | 53 | 42 | 7 |
| Q4 2018 | 32 | 53 | 57 | 37 | 8 |
| Q1 2019 | 33 | 65 | 46 | 27 | 22 |
| Q2 2019 | 28 | 60 | 48 | 32 | 17 |
| Q3 2019 | 16 | 62 | 52 | 24 | 24 |
| Q4 2019 | 61 | 65 | 47 | 19 | 26 |
| Q1 2020 | 25 | 67 | 48 | 52 | -4 |
| Q2 2020 | 56 | 76 | 50 | 15 | 32 |
| Q3 2020 | 44 | 80 | 56 | 42 | 9 |
| Q4 2020 | 102 | 84 | 69 | 30 | 17 |
| Q1 2021 | 59 | 115 | 70 | 61 | -7 |
| Q2 2021 | 48 | 105 | 82 | 42 | 27 |
| Q3 2021 | 52 | 96 | 94 | 48 | 13 |
| Q4 2021 | 52 | 86 | 88 | 62 | 9 |
| Q1 2022 | 28 | 78 | 64 | 81 | -12 |
| Q2 2022 | 37 | 72 | 66 | 37 | 25 |
Hedge funds changes in Editas Medicine stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 6,765,000 | 9,709,000 |
|---|---|---|
| Q4 2017 | 13,473,000 | 19,958,000 |
| Q1 2018 | 47,939,000 | 35,370,000 |
| Q2 2018 | 6,000,040,349,000 | 27,135,000 |
| Q3 2018 | 25,157,000 | 20,935,000 |
| Q4 2018 | 1,000,020,324,000 | 18,164,000 |
| Q1 2019 | 7,033,000 | 26,515,000 |
| Q2 2019 | 8,509,000 | 14,695,000 |
| Q3 2019 | 8,119,000 | 15,193,000 |
| Q4 2019 | 32,039,000 | 29,345,000 |
| Q1 2020 | 21,119,000 | 11,728,000 |
| Q2 2020 | 47,360,000 | 13,239,000 |
| Q3 2020 | 33,279,000 | 14,314,000 |
| Q4 2020 | 188,389,000 | 134,465,000 |
| Q1 2021 | 97,141,000 | 73,195,000 |
| Q2 2021 | 203,010,000 | 125,507,000 |
| Q3 2021 | 92,658,000 | 189,595,740 |
| Q4 2021 | 23,849,330 | 56,073,385 |
| Q1 2022 | 31,159,228 | 31,896,414 |
| Q2 2022 | 19,704,720 | 20,825,359 |